Clinical role and efficacy of landiolol in the intensive care unit

Journal of Anesthesia

Volumn 22, Issue 1, 2008, Pages 64-69

  Yoshida, Yuko ^a   Terajima, Katsuyuki ^a   Sato, Chiyo ^a   Akada, Shinji ^a,b   Miyagi, Yasuo ^b   Hongo, Takashi ^a,b   Takeda, Shinhiro ^a,b   Tanaka, Keiji ^b   Sakamoto, Atsuhiro ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NIPPON MEDICAL SCHOOL HOSPITAL   (Japan)

Author keywords

Atrial fibrillation; Beta adrenergic receptor blocker; Intensive care unit; Landiolol; Myocardial ischemia

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; LANDIOLOL; METOPROLOL; SOTALOL;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDICATION; FEMALE; HEART ATRIUM FIBRILLATION; HEART MUSCLE ISCHEMIA; HEART RATE; HEMODYNAMICS; HUMAN; INTENSIVE CARE UNIT; INTERNAL MEDICINE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; RETROSPECTIVE STUDY;

ADRENERGIC BETA-ANTAGONISTS; AGED; ATRIAL FIBRILLATION; BLOOD PRESSURE; CATECHOLAMINES; FEMALE; HEART RATE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MORPHOLINES; MYOCARDIAL ISCHEMIA; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; UREA;

EID: 40349098603     PISSN: 09138668     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00540-007-0573-3     Document Type: Article

References (33)

1. Yusuf S, Peto R, Lewis J, Collins R, Sleight P (1985) Beta blockade during and after myocardial infarction: An overview of the randomized trials. Prog Cardiovasc Dis 27:335-371
2. ISIS-1. First International Study of Infarct Survival Collaborative group (1986) Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction. Lancet 12:57-66
3. The MIAMI Trial Research Group (1985) Metoprolol in acute myocardial infarction (MIAMI). A randomized placebo-controlled international trial. Eur Heart J 6:199-226
4. Martinez EA, Epstein AE, Bass EB (2005) Pharmacologic control of ventricular rate: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 128:56-60
5. Cristal E, Healey J, Connolly SJ (2003) Atrial fibrillation after cardiac surgery: Update on the evidence on the available prophylactic interventions. Card Electrophysiol Rev 7:189-192
6. Reiter MJ, Reiffel J (1998) Importance of beta blockade in the therapy of serious ventricular arrhythmias. Am J Cardiol 82: 9-19
7. Van Dantzig JM, Koster RW, Biervliet JD (1991) Treatment with esmolol of ventricular fibrillation unresponsive to lidocaine and procainamide. J Cardiothorac Vasc Anesth 5:600-603
8. Atarashi H, Kuruma A, Yashima M, Saitoh H, Ino T, Endoh Y, Hayakawa H (2000) Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting β-blocker, in patients with cardiac arrhythmias. Clin Pharmacol Ther 68:143-150
9. Killingsworth CR, Wei CC, Dell'Italia LJ, Ardell JL, Kingsley MA, Smith WM, Ideker RE, Walcott GP (2004) Short-acting β-adrenergic antagonist esmolol given at reperfusion improves survival after prolonged ventricular fibrillation. Circulation 109:2469-2474
10. Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, Lemaitre RN, Wagner EH, Furberg CD (1997) Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 277:739-745
11. Turnbull F: Blood Pressure Lowering Treatment Trialists' Collaboration (2003) Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively designed overviews of randomised trials. Lancet 362:1527-1535
12. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, Schultz MK, DeMets DL; Carvedilol Prospective Randomized Cumulative Survival Study Group (2001) Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344:1651-1658
13. Doughty RN, Rodgers A, Sharpe N, MacMahon S (1997) Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials. Eur Heart J 18:560-565
14. Boersma E, Poldermants D, Bax JJ, Steyerberg EW, Thomson IR, Banga JD, Ven LLM, Urk H, Roelandt JRTC (2001) Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA 285:1865-1873
15. Mangano DT, Layug EL, Wallance A, Tateo I (1996) Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 335:1713-1720
16. Iguchi S, Iwamura H, Nishizaki M, Hayashi A, Senokuchi K, Kobayashi K, Sakaki K, Hachiya K, Ichioka Y, Kawamura M (1992) Development of a highly cardioselective ultra short-acting β-blocker, ONO-1101. Chem Pharm Bull 40:1462-1469
17. 1-blocking agent in healthy volunteers (in Japanese with English abstract). Rinsyoiyaku (J Clin Ther Med) 13:4823-4850
18. Yoshida Y, Hongo T, Sakamoto A, Ogawa R (2005) Successful management of tachycardiac atrial fibrillation in a septic patient with landiolol. Anesth Analg 100:294-295
19. Satoh N, Kobayashi K, Kitoh T, Otagiri T (2006) Effect of landiolol on heart rate control of atrial fibrillation in a patient with sick sinus syndrome under ventricular pacing (in Japanese with English abstract). Masui (Jpn J Anesthesiol) 55:1161-1163
20. Kobayashi Y, Osone J, Kiya T, Tsujiguchi N, Yoshikawa O (2004) Low dose landiolol for the treatment of intraoperative tachyarrhythmias in four patients with cardiovascular complications (in Japanese with English abstract). Rinsyomasui (J Clin Anesth (Jpn)) 28:877-879
21. Yoshiya I, Ogawa R, Okumura F, Shimada Y, Hanaoka K (1997) Clinical evaluation of landiolol hydrochloride (ONO-1101) on perioperative supraventricular tachyarrhythmia. A phase III, double-blind study in comparison with placebo-(in Japanese with English abstract) Rinsyoiyaku (J Clin Ther Med) 13:4949-4978
22. Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankensteijn JD, Baars HF, Yo TI, Trocino G, Vigna C, Roelandt JR, van Urk H (1999) The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 341:1789-1794
23. Wallace A, Layug B, Tateo I, Li J, Hollenberg M, Browner W, Miller D, Mangano DT (1998) Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology 88:7-17
24. Stone JG, Foex P, Sear JW, Johnson LM, Khambatta HJ, Triner L (1988) Myocardial ischemia in untreated hypertensive patients: Effect of a single small oral dose of a beta-adrenergic blocking agent. Anesthesiology 68:495-500
25. Pasternack PF, Imparato AM, Baumann FG, Laub G, Riles TS, Lamparello PJ, Grossi EA, Berquson P, Becker G, Bear G (1987) The hemodynamics of β-blockade in patiens undergoing abdominal aneurysm repair. Circulation 76(Suppl III):1-7
26. Pasternack PF, Grossi EA, Baumann FG, Riles TS, Lamparello PJ, Giangola G, Primis LK, Mintzer R, Imparato AM (1989) Beta-blockade to decrease silent myocardial ischemia during peripheral vascular surgery. Am J Surg 158:113-116
27. Yeager RA, Moneta GL, Edwards JM, Taylor LM Jr, McConnell DB, Porter JM (1995) Reducing perioperative myocardial infarction following vascular surgery. The potential role of β-blockade. Arch Surg 130:869-873
28. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, Fleisher LA, Froehlich JB, Gusbertg RJ, Leppo JA, Ryan T, Schlant RC, Winters WL Jr, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SC Jr (2002) ACC/ AHA Guideline update for perioperative cardiovascular evaluation for noncardiac surgery executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 105:1257-1267
29. American College of Physicians (1997) Guidelines for assessing and managing the perioperative risk from coronary artery disease associated with major noncardiac surgery. Ann Intern Med 127:309-312
30. Fillinger MP, Surgenor SD, Hartmann GS, Clark C, Dodds TM, Rassias AJ, Paganelli WC, Marshall P, Johnson D, Kelly D, Galatis D, Olmstead EM, Ross CS, O'Connor GT (2002) The association between heart rate and in-hospital mortality after coronary artery bypass graft surgery. Anesth Analg 95:1483-1488
31. Gillespie EL, White CM, Kluger J, Sahni J, Gallagher R, Coleman CI (2005) A hospital perspective on the cost-effectiveness of beta-blockade for prophylaxis of atrial fibrillation after cardiothoracic surgery. Clin Ther 27:1963-1969
32. Terajima K (2004) Usage in ICU and new indications for landiolol. In: Ogawa R (ed) Use of beta-adrenergic receptor blockers perioperatively (in Japanese). Shinkokoeki, Tokyo, pp 233-241
33. Shammash JB, Trost JC, Gold JM, Berlin JA, Golden MA, Kimmel SE (2001) Perioperative β-blocker withdrawal and mortality in vascular surgical patients. Am Heart J 141:148-153